244 related articles for article (PubMed ID: 29233672)
1. Time latencies of Helicobacter pylori eradication after peptic ulcer and risk of recurrent ulcer, ulcer adverse events, and gastric cancer: a population-based cohort study.
Sverdén E; Brusselaers N; Wahlin K; Lagergren J
Gastrointest Endosc; 2018 Aug; 88(2):242-250.e1. PubMed ID: 29233672
[TBL] [Abstract][Full Text] [Related]
2. Early Helicobacter pylori eradication decreases risk of gastric cancer in patients with peptic ulcer disease.
Wu CY; Kuo KN; Wu MS; Chen YJ; Wang CB; Lin JT
Gastroenterology; 2009 Nov; 137(5):1641-8.e1-2. PubMed ID: 19664631
[TBL] [Abstract][Full Text] [Related]
3. Effect of Helicobacter pylori eradication therapy on risk of hospitalization for a major ulcer event.
Hsiao FY; Tsai YW; Wen YW; Kuo KN; Tsai CR; Huang WF
Pharmacotherapy; 2011 Mar; 31(3):239-47. PubMed ID: 21361733
[TBL] [Abstract][Full Text] [Related]
4. Early eradication has a lower risk of peptic ulcer bleeding in Helicobacter pylori-infected chronic kidney disease patients.
Hsu CH; Hu HY; Huang N; Chang SS
Eur J Intern Med; 2016 Sep; 33():112-7. PubMed ID: 27449117
[TBL] [Abstract][Full Text] [Related]
5. Characteristics of gastric cancer in peptic ulcer patients with Helicobacter pylori infection.
Hwang JJ; Lee DH; Lee AR; Yoon H; Shin CM; Park YS; Kim N
World J Gastroenterol; 2015 Apr; 21(16):4954-60. PubMed ID: 25945009
[TBL] [Abstract][Full Text] [Related]
6. Helicobacter pylori Eradication within 120 Days Is Associated with Decreased Complicated Recurrent Peptic Ulcers in Peptic Ulcer Bleeding Patients.
Chang SS; Hu HY
Gut Liver; 2015 May; 9(3):346-52. PubMed ID: 25167793
[TBL] [Abstract][Full Text] [Related]
7. Association between early Helicobacter pylori eradication and a lower risk of recurrent complicated peptic ulcers in end-stage renal disease patients.
Chang SS; Hu HY
Medicine (Baltimore); 2015 Jan; 94(1):e370. PubMed ID: 25569660
[TBL] [Abstract][Full Text] [Related]
8. The effect of eradicating helicobacter pylori on the development of gastric cancer in patients with peptic ulcer disease.
Take S; Mizuno M; Ishiki K; Nagahara Y; Yoshida T; Yokota K; Oguma K; Okada H; Shiratori Y
Am J Gastroenterol; 2005 May; 100(5):1037-42. PubMed ID: 15842576
[TBL] [Abstract][Full Text] [Related]
9. H. pylori eradication lower ulcers in cirrhosis. [Corrected].
Chang SS; Hu HY
J Dig Dis; 2014 Aug; 15(8):451-8. PubMed ID: 24825443
[TBL] [Abstract][Full Text] [Related]
10. The results of Helicobacter pylori eradication on repeated bleeding in patients with stomach ulcer.
Horvat D; Vcev A; Soldo I; Timarac J; Dmitrović B; Misević T; Ivezić Z; Kraljik N
Coll Antropol; 2005 Jun; 29(1):139-42. PubMed ID: 16117312
[TBL] [Abstract][Full Text] [Related]
11. Baseline gastric mucosal atrophy is a risk factor associated with the development of gastric cancer after Helicobacter pylori eradication therapy in patients with peptic ulcer diseases.
Take S; Mizuno M; Ishiki K; Nagahara Y; Yoshida T; Yokota K; Oguma K
J Gastroenterol; 2007 Jan; 42 Suppl 17():21-7. PubMed ID: 17238021
[TBL] [Abstract][Full Text] [Related]
12. Eradication of Helicobacter pylori improves the healing rate and reduces the relapse rate of nonbleeding ulcers in patients with bleeding peptic ulcer.
Arkkila PE; Seppälä K; Kosunen TU; Haapiainen R; Kivilaakso E; Sipponen P; Mäkinen J; Nuutinen H; Rautelin H; Färkkilä MA
Am J Gastroenterol; 2003 Oct; 98(10):2149-56. PubMed ID: 14572560
[TBL] [Abstract][Full Text] [Related]
13. [Secondary and primary prophylaxis of gastropathy associated with nonsteroidal antiinflammatory drugs or low-dose-aspirin: a review based on four clinical scenarios].
Limmer S; Ittel TH; Wietholtz H
Z Gastroenterol; 2003 Aug; 41(8):719-28. PubMed ID: 12910426
[TBL] [Abstract][Full Text] [Related]
14. Seventeen-year effects of eradicating Helicobacter pylori on the prevention of gastric cancer in patients with peptic ulcer; a prospective cohort study.
Take S; Mizuno M; Ishiki K; Hamada F; Yoshida T; Yokota K; Okada H; Yamamoto K
J Gastroenterol; 2015 Jun; 50(6):638-44. PubMed ID: 25351555
[TBL] [Abstract][Full Text] [Related]
15. Highly significant change of the clinical course of relapsing and complicated peptic ulcer disease after cure of Helicobacter pylori infection.
Labenz J; Börsch G
Am J Gastroenterol; 1994 Oct; 89(10):1785-8. PubMed ID: 7942667
[TBL] [Abstract][Full Text] [Related]
16. Maintenance treatment is not necessary after Helicobacter pylori eradication and healing of bleeding peptic ulcer: a 5-year prospective, randomized, controlled study.
Liu CC; Lee CL; Chan CC; Tu TC; Liao CC; Wu CH; Chen TK
Arch Intern Med; 2003 Sep; 163(17):2020-4. PubMed ID: 14504114
[TBL] [Abstract][Full Text] [Related]
17. Persistence of Helicobacter pylori infection in patients with peptic ulcer perforation.
Andreson H; Sillakivi T; Peetsalu M; Peetsalu A; Mikelsaar M
Scand J Gastroenterol; 2007 Mar; 42(3):324-9. PubMed ID: 17354111
[TBL] [Abstract][Full Text] [Related]
18. [Helicobacter pylori and digestive hemorrhage due to duodenal ulcer: the prevalence of the infection, the efficacy of 3 triple therapies and the role of eradication in preventing a hemorrhagic recurrence].
Gisbert JP; Boixeda D; Aller R; de la Serna C; Sanz E; Martín de Argila C; Abraira V; García Plaza A
Med Clin (Barc); 1999 Feb; 112(5):161-5. PubMed ID: 10091208
[TBL] [Abstract][Full Text] [Related]
19. The influence of the eradication of Helicobacter pylori on gastric ghrelin, appetite, and body mass index in patients with peptic ulcer disease.
Jang EJ; Park SW; Park JS; Park SJ; Hahm KB; Paik SY; Sin MK; Lee ES; Oh SW; Park CY; Baik HW
J Gastroenterol Hepatol; 2008 Dec; 23 Suppl 2():S278-85. PubMed ID: 19120912
[TBL] [Abstract][Full Text] [Related]
20. Clinical characteristics of peptic ulcer perforation in Korea.
Yang YJ; Bang CS; Shin SP; Park TY; Suk KT; Baik GH; Kim DJ
World J Gastroenterol; 2017 Apr; 23(14):2566-2574. PubMed ID: 28465641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
